menu
    • menu

    Company profile for Vaxxas

    NEW Drugs in Dev: 9
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vaxxas is a privately held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its proprietary HD-MAP technology platform, which uses an ultra-high density array of projections – invisible to the naked human eye – applied to the skin to rapidly deliver vaccine to the abundant immune cells immediately below the skin surface. This approach can enhance efficiency and effect...
    Vaxxas is a privately held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its proprietary HD-MAP technology platform, which uses an ultra-high density array of projections – invisible to the naked human eye – applied to the skin to rapidly deliver vaccine to the abundant immune cells immediately below the skin surface. This approach can enhance efficiency and effectiveness of immune response.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VaxxasUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    47 Thorndike Street, Suite B1-1 Cambridge, Massachusetts 02141 USA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vaxxas.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vaxxas/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SK Bioscience, IDT, Vaxxas Picked for EU Flu Vaccine Program
    SK Bioscience, IDT, Vaxxas Picked for EU Flu Vaccine Program

    26 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sk-bioscience-idt-biologika-and-vaxxas-selected-for-next-generation-influenza-vaccine-development-financed-by-the-european-union-302697969.html

    PR NEWSWIRE
    26 Feb 2026
    Share Share
    Vaxxas Names Ex-Merck Global Vaccines Head David Peacock CEO
    Vaxxas Names Ex-Merck Global Vaccines Head David Peacock CEO

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214498/0/en/Vaxxas-Appoints-Former-Merck-Global-Vaccines-President-David-Peacock-as-CEO.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Vaxxas Secures TGA Licence To Manufacture Therapeutic Goods
    Vaxxas Secures TGA Licence To Manufacture Therapeutic Goods

    14 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/14/3205032/0/en/Vaxxas-Secures-TGA-Licence-to-Manufacture-Therapeutic-Goods.html

    GLOBENEWSWIRE
    14 Dec 2025
    Share Share
    Vaxxas Appoints Veteran Vaccine Leader to Board
    Vaxxas Appoints Veteran Vaccine Leader to Board

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184484/0/en/Vaxxas-Appoints-Veteran-Vaccine-Leader-to-Board-as-Company-Advances-Needle-Free-Vaccine-Patch-Towards-Market.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    ObvioHealth, Vaxxas Partner on Needle-Free Vaccine Tech Trials
    ObvioHealth, Vaxxas Partner on Needle-Free Vaccine Tech Trials

    28 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/obviohealth-and-vaxxas-sign-multi-year-agreement-to-power-needle-free-vaccination-technology-trials-with-obviogo-302595623.html

    PR NEWSWIRE
    28 Oct 2025
    Share Share
    Vaxxas Secures A$90M To Advance Needle-Free Vaccine Tech
    Vaxxas Secures A$90M To Advance Needle-Free Vaccine Tech

    25 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/25/3138224/0/en/Vaxxas-secures-A-90-million-in-funding-to-commercialise-needle-free-vaccination-delivery-technology.html

    GLOBENEWSWIRE
    25 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search